Podcasts about cti

Access this entire 70-minute episode (and additional monthly bonus episodes) by becoming a Junk Filter patron! https://www.patreon.com/junkfilter/posts/232-herb-alpert-165373100The Toronto-based musician Marker Starling (aka Chris Cummings) returns to the pod for a discussion of the career of Herb Alpert, who at age 91 is on tour with his new lineup of the Tijuana Brass; we went together to see his Toronto show at Massey Hall.It is hard to imagine today, but during the sixties only The Beatles dominated the American pop charts more thoroughly than Herb Alpert & the Tijuana Brass, who famously landed four albums in the Billboard Top 10 simultaneously in 1966. Their era-defining smash, 1965's Whipped Cream & Other Delights, served as a sonic harbinger of the massive cultural changes about to sweep America. The band's music quickly became ubiquitous, soundtracking everything from commercial jingles and game shows to house parties. Interestingly, while framed as a band, many of their early albums were secretly recorded by the legendary LA session musician unit The Wrecking Crew. Though changing musical tastes eventually landed millions of these vinyl records in garage sales and dollar bins, their cultural legacy remains, as evidenced by hip-hop samples and viral TikTok memes.We discuss all 13 Tijuana Brass albums but also explore Alpert's visionary work co-founding A&M Records, including key signings like The Carpenters, Chris Montez, and Sergio Mendes & Brasil '66. Finally, we discuss Herb's collaborations with Burt Bacharach and Hal David, the massive influence of A&M's jazz label CTI in mainstreaming bossa nova via Antonio Carlos Jobim and Quincy Jones, and tell you what it was like to get to finally see Herb & the Brass in concert. Follow Marker Starling on Twitter and Instagram.Here are links to Chris' most recent releases:Lammping/Marker Starling/Drew Smith - RISKY (2026)Cici Arthur - Way Through (2025)Marker Starling - Diamond Violence (2022)Herb Alpert music videosThis Guy's In Love With You (1967)Rise (1979)Route 101 (1982)

On today's CTI, Andy & DJ discuss the online backlash after Dr. Anthony Fauci invoked the Fifth Amendment as conservatives reignited debate over COVID-19 lockdown policies, the White House criticizing Spain after a surge of migrants from Morocco reportedly strained border resources, and a bizarre scene at a WNBA game where the wife of a Seattle Storm co-owner allegedly berated young girls carrying signs supporting Sophie Cunningham and women's sports.

In this episode of Unspoken Security, host AJ Nash sits down with Heath Mullins, Chief Evangelist at ExtraHop and former senior analyst at Forrester. The two dig into the question everyone in tech keeps circling back to right now: should we be afraid of AI?Mullins argues that today's AI is best understood as a recalcitrant four-year-old handed the keys to everything, powerful, unpredictable, and rewriting itself faster than anyone can fully audit. AJ and Heath trace that unpredictability through self-driving cars that can't tell a yawn from drunk driving, medical offices where AI now transcribes and recommends diagnoses, and the accountability gap that opens up when something goes wrong and nobody, the automaker, the AI vendor, or a third party, wants to own it.The conversation closes on Unspoken Security's signature question, and Heath shares something he's never said publicly before: his son was murdered in 2020, and the same AI tools that can recreate a voice or a likeness from old recordings and social media now make it possible to build an avatar of someone who's gone. Heath draws a hard line on where that technology should stop, and AJ and Heath talk through the psychology of grief, denial, and why loss makes that temptation so powerful.Send us Fan MailSupport the show

What's driving Cincinnati's rise as one of the Midwest's most dynamic economic engines? In this episode of Develop This!, Dennis Fraise speaks with Kimm Lauterbach, CEO of REDI Cincinnati, about the region's rapid growth and the strategies positioning it as a national leader in innovation, investment, and industry. Kimm shares how Cincinnati has built momentum through a combination of regional collaboration, strong industry clusters, and a commitment to workforce development. The conversation highlights how partnerships across state lines are helping the region compete more effectively for investment and talent. A major focus is Cincinnati's growing strength in life sciences and biopharma, where companies such as Medpace and CTI have helped establish the region as a recognized hub for research, innovation, and commercialization. The discussion also explores the region's leadership in aerospace, advanced manufacturing, and food innovation—industries that continue to drive economic growth while creating opportunities for workforce development and business expansion. Looking ahead, Kimm discusses the role of innovation districts, research partnerships, and international investment in shaping Cincinnati's future and sustaining long-term competitiveness. A key takeaway? Cincinnati's success is built on collaboration, industry specialization, and a clear vision for regional growth. Key Takeaways Cincinnati is experiencing strong economic growth across multiple industries Regional collaboration strengthens competitiveness and investment attraction Life sciences and biopharma have become major economic drivers Aerospace and advanced manufacturing remain key regional strengths Workforce development supports long-term industry growth Innovation districts and research partnerships are fueling future opportunities Foreign direct investment continues to play an important role in expansion Key Topics Covered Cincinnati's economic growth and recognition Foreign direct investment and international companies Regional multi-state collaboration strategies Life sciences and biopharma development Workforce development and training programs Aerospace and advanced manufacturing Food and beverage innovation Innovation districts and research partnerships Sound Bites "Success stories like Medpace and CTI." "Overindexing in aerospace engineering." "Regional collaboration creates greater opportunity."

What happens behind the scenes to ensure new therapies are safe for patients? In this episode of Moving Medicine Forward, we are joined by John Kane, Vice President of Pharmacovigilance and Safety Services at CTI, to explore the critical role of drug safety throughout the clinical development process. John shares how safety teams collect and evaluate adverse event data, navigate complex global regulations, and help protect patients from clinical trials through post-market surveillance. He also discusses the growing impact of AI in pharmacovigilance, the continued growth of North Carolina's Research Triangle, and the rewarding career opportunities available in clinical research. 01:13 – Finding a Career in Clinical Research John shares how he transitioned from nursing into the clinical research industry.  02:14 – CTI's Growth in Raleigh Why North Carolina's Research Triangle continues to attract biotech companies and research talent. 04:55 – Understanding Pharmacovigilance What pharmacovigilance is and how safety teams collect, evaluate, and report adverse events throughout a drug's lifecycle. 07:33 – Protecting Patients Through Drug Development How CTI safety teams monitor risks, identify safety signals, and communicate important findings to regulators and investigators. 09:55 – Navigating Global Regulations The growing complexity of global safety reporting requirements and regulatory compliance. 11:51 – The Role of AI in Drug Safety How AI may improve data processing, signal detection, and scientific literature review. 13:53 – A COVID-19 Success Story John reflects on supporting a large COVID-19 trial and managing high volumes of safety data. 14:38 – Collaboration at CTI Why teamwork and collaboration are key to successful clinical trials and patient impact.  15:32 – Advice for Future Research Professionals Career opportunities in clinical research and how CTI helps new professionals enter the field.

Security Conversations: Kenneth Kinion, founder and CEO of Validin, joins Ryan Naraine on the show to unpack what "internet intelligence" really means for the analysts and responders chasing malicious infrastructure. We trace his path from Georgia Tech through Microsoft and Amazon to the frustrations that led to the creation of Validin, the competition from big AI, the value of AI-powered tools to speed up infrastructure hunting, and why defenders keep falling further behind fast-moving attackers. Timestamps: 0:00 – Intro: What does Validin do? 0:51 – Who uses Validin: CTI teams, SOCs, incident responders 2:19 – Atlanta and Georgia Tech's cybersecurity pipeline 5:31 – Lessons from Microsoft and Amazon: waterfall vs. agile 8:29 – Filling gaps in passive DNS data 9:57 – Misunderstood things about threat intelligence 14:17 – The value of "cyber paleontology" 16:00 – What makes one data set better than another? 19:39 – How Validin works: from one suspicious domain to a full pivot 21:27 – AI as existential threat or force multiplier for Validin 26:55 – Dual-use AI: are defenders losing ground to attackers? 31:11 – Closing: the next hard problem Validin wants to solve

On today's CTI, Andy and DJ discuss the House passing a $1.15T defense bill with Israel provision, Taco Bell slashing the price of one of its fan favorite menu items to $1 for a day, and Sophie Cunningham after her common sense comments on transgender athletes.

What does it take to set a complex global clinical trial up for success? In this episode of Moving Medicine Forward, we are joined by Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient centered decision-making, biometrics strategy, and global expansion, they share insights into the operational challenge —and opportunities—behind bringing innovative therapies to patients faster.   01:22 Megan Kamm and Josh Schroeder discuss their expanded leadership roles and growing collaboration across teams. 03:44 Why feasibility, country strategy, and study startup are critical to trial success. 05:07 The importance of site partnerships, patient experience, and reducing operational burden.06:16 How project managers, CRAs, data managers, and site teams work together to execute complex trials. 07:01 Common startup challenges and strategies for keeping studies on track. 08:13 Managing patient-centered logistics in rare disease and cell & gene therapy programs. 11:15 Real-world examples of strong coordination improving enrollment and accelerating timelines. 13:19 The growing role of biometrics, statistics, and risk-based monitoring in study execution. 15:15 Scaling global teams through consistent training, leadership alignment, and operational excellence. 16:48 What differentiates CTI: collaboration, service, and a deep commitment to patients. 18:59 Looking ahead: AI, technology, startup optimization, and continued global growth. 21:05 Opportunities and challenges of expanding operations in China and the APAC region.

Asia Pacific has become one of the fastest-growing regions in clinical research, offering sponsors new opportunities to advance clinical development in an increasingly complex global environment.In this episode, Pavels Anetko, Director of Clinical Operations and Clinical Project Management at CTI, shares insights from across the region, including Australia's strengths in early phase studies and CTI's recent expansion into China and Japan.  01:24 Pavels' background, career journey, and leadership role overseeing CTI's project management teams across Asia Pacific. 02:13 Why APAC is one of the fastest-growing regions for clinical development and the increasing influence of China. 02:41 CTI's growth strategy in Australia and the region's advantages for early-phase research, including the CTN regulatory pathway and R&D tax incentives. 04:06 The rise of healthy volunteer and Phase I studies in Australia. 04:27 Building CTI's presence in China and Japan and navigating more complex regulatory environments. 05:05 Staying aligned with regional regulatory requirements while maintaining global clinical trial standards. 05:40 How CTI helps sponsors select the right countries, sites, and patient populations across APAC. 06:20 Why local infrastructure, language expertise, and in-country teams are critical to trial success. 07:09 Challenges sponsors face when entering new APAC markets and how local support reduces risk. 07:36 The strategic value of including Japan and China in global studies, including access to patients and regulatory considerations. 08:58 How APAC can accelerate development timelines and strengthen regulatory submissions. 09:38 Key operational considerations for global studies, including logistics, specimen handling, and country-specific requirements.  10:08 Emerging opportunities across APAC, including growth in Southeast Asia and expanding clinical research markets.  10:54 Pavels shares career highlights, including gene therapy studies in Australia and supporting COVID-19 vaccine trials in Singapore.  12:44 Closing thoughts on the future of APAC and its growing influence on global clinical development.

Host Luke McNamara is joined by Jake Nicastro, who leads the AI function for the Frontline Intelligence Operations team within the Google Threat Intelligence Group (GTIG). Jake details how his team is shifting from simple prompt engineering to more advanced agentic workflows, focusing on a model of "human-machine teaming." He shares practical use cases for AI in CTI—including automated script decoding, hunting query creation, and streamlining repetitive metadata-labeling tasks. Jake also discusses the concept of "judge agents" for quality control, the implementation of structured analytic techniques, and how real-time AI assistants can accelerate on-boarding and domain transitions for frontline threat analysts.

Frente de guerra oriental del ELN entregó pruebas de supervivencia de dos funcionarios del CTI

In this episode of Unspoken Security, AJ Nash and Faith MacGregor tackle the private sector's sloppy relationship with the word "intelligence" — the gap between raw data, contextual information, and verified, actionable intelligence — and how vendors, circular reporting, and fragmented disciplines like "cyber threat intelligence" have eroded that discipline. From there they turn to AI, weighing real utility against real danger: hallucinations that persist even with vetted sources, analysts pulled toward premature conclusions under time pressure, and the EY finding that roughly 40% of AI-generated conclusions had to be recalled. Nash's sharpest line - if a human analyst behaved this way, you'd fire them - sets up a back half that's cautiously optimistic, pointing to Recorded Future's human-curated, AI-assisted model as a template, while widening the lens to AI in government targeting decisions and the quiet brain drain hollowing out the intelligence profession. Send us Fan MailSupport the show

Summer Farmen and Jeff Sturm share their personal cancer journeys and the mission behind ALK Positive, CTI's Q3 Charity of the Quarter.ALK Positive is a patient-driven organization dedicated to improving outcomes for individuals living with ALK-positive cancer.Together, they discuss how they became advocates within a global patient community, the importance of genetic testing and second opinions, and the role of research initiatives and clinical trials in advancing treatment options and improving patient outcomes.00:00 Introduction to ALK Positive and today's guests, Summer Farmen and Jeff Sturm. 01:14 Summer and Jeff share their personal cancer journeys and what led them to become advocates within the ALK Positive community. 02:33 The mission of ALK Positive: connecting patients, funding research, and ensuring no one faces the diagnosis alone. 03:49 Why second opinions matter and how specialized expertise can significantly impact treatment decisions.  06:19 Research initiatives supported by ALK Positive, including clinical trials, grants, and collaborations focused on new treatment approaches. 10:46 Challenging the perception of ALK-positive cancer as a “rare” disease and advocating for greater representation in research and clinical trials. 13:22 How targeted therapies have transformed outcomes and extended survival for many ALK-positive patients.15:47 The realities of survivorship: managing side effects, quality of life, and the role of palliative care. 17:27 The importance of genetic testing, monitoring disease progression, and making informed treatment decisions. 21:15 Clinical trial participation: common barriers, improving access, and helping patients connect with opportunities. 26:16 Building community through support groups, education programs, Healing Arts initiatives, and patient connections.  28:46 Addressing the emotional and mental health challenges that often accompany a cancer diagnosis. 32:50 Looking ahead: emerging therapies, vaccine research, precision medicine, and the future of ALK-positive cancer treatment. 36:51 Resources available through ALK Positive and how patients and caregivers can get involved.  37:54 Closing thoughts on advocacy, community, and the patient voices helping shape the future of cancer research.

Zámecký areál v Březnici na Příbramsku ve středních Čechách je i dnes vyhledávaným místem pro romantické svatby. V 16. století byl ale na zámku uzavřen tajný sňatek, ze kterého císař radost neměl. Manželství se později zapsalo do dějin jako jedno z nejšťastnějších v historii habsburského rodu. Příběh zamilovaného Ferdinanda II. a jeho Filipíny zachytil spisovatel Antonín Polách v románu Cti otce svého, ale miluj ženu svou.

Zámecký areál v Březnici na Příbramsku ve středních Čechách je i dnes vyhledávaným místem pro romantické svatby. V 16. století byl ale na zámku uzavřen tajný sňatek, ze kterého císař radost neměl. Manželství se později zapsalo do dějin jako jedno z nejšťastnějších v historii habsburského rodu. Příběh zamilovaného Ferdinanda II. a jeho Filipíny zachytil spisovatel Antonín Polách v románu Cti otce svého, ale miluj ženu svou.Všechny díly podcastu Výlety můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

Zámecký areál v Březnici na Příbramsku ve středních Čechách je i dnes vyhledávaným místem pro romantické svatby. V 16. století byl ale na zámku uzavřen tajný sňatek, ze kterého císař radost neměl. Manželství se později zapsalo do dějin jako jedno z nejšťastnějších v historii habsburského rodu. Příběh zamilovaného Ferdinanda II. a jeho Filipíny zachytil spisovatel Antonín Polách v románu Cti otce svého, ale miluj ženu svou.

Amos 7,1-9 1Toto mi ukázal Pán, Hospodin:Tvoril kobylky,keď začala rásť mládza,a hľa, bola to mládza po kráľovskej kosbe.2Keď mali zožrať všetku zeleň krajiny, povedal som:„Pane, Hospodin, odpusť!Ako obstojí Jákob?Veď je primalý.“3Hospodin sa zľutoval v tej veci.„Nestane sa!“ riekol Hospodin.4Toto mi ukázal Pán, Hospodin:„Hľa, Pán, Hospodin, vyhlásil súd ohňoma ten pohltil veľkú priepasťa pohltil i diel zeme.“5Vtedy som povedal:„Pane, Hospodin, prestaň, prosím!Ako obstojí Jákob?Veď je primalý.“6Hospodin sa zľutoval:„Ani to sa nestane,“riekol Pán, Hospodin.7Toto mi ukázal:„Hľa, Pán stál pri múrepostavenom podľa olovnicea v ruke mal olovnicu.“8Potom mi povedal Hospodin:„Čo vidíš, Amos?“Odpovedal som: „Olovnicu.“Pán povedal:„Hľa, kladiem olovnicudo stredu môjho izraelského ľudu.Už mu viac neodpustím.9Spustnú výšiny Izáka,izraelské svätyne budú zrúcanéa proti Jarobeámovmu domu postavím sa s mečom.“ Olovnica. Hovorí sa, že v jednoduchosti je krása. V jednoduchosti býva aj dokonalosť. Napríklad taká olovnica – šnúrka so závažím dokonale ukáže kolmicu týčiacu sa nad zemou. Aj Božie zákony sa podobajú olovnici. Tak ako je pre šnúrku s visiacim závažím prirodzené vytvoriť rovnú úsečku, Božie slovo nám ukazuje celkom prirodzenú cestu k dobrému životu: Cti si rodičov, nepokradneš, miluj svojho Stvoriteľa i svojho blížneho ako seba samého atď. Na tom nie je nič zvláštne, žiadna Božia záľuba v panovačnosti, ale len to, čo nám celkom logicky pomôže dobre žiť. Prečo však naše životy bývajú akési krivé, pokrútené a nepodobné olovnici? Niekedy stačí len nepatrná odchýlka na začiatku, ktorá sa čím ďalej, tým viac zväčšuje, až sa začneme podobať viac na šikmú vežu v Pise, než na dokonale kolmú šnúrku olovnice. Niečo je tu zle. Akoby pre človeka tým najprirodzenejším bolo byť neprirodzený. Žiaľ, sme hriešni, a tak aj do svojho stredu potrebujeme dať olovnicu, aby sme videli naše vychýlenia. Na jednej strane je to možno odklon do ľahostajnosti, do ktorej upadali aj Ámosovi súčasníci. Na druhej strane to môže byť aj neláskavé zákonníctvo. Nech sám Boh premieňa naše srdcia i myseľ, aby láska a spravodlivosť boli pre nás celkom prirodzeným vyjadrením nášho vzťahu k dokonalému Bohu! Modlitba: Bože, ďakujem Ti, že nás duchovne narovnávaš! Odpusť, že mám niekedy radšej krivé chodníčky! Daj, nech sa vo mne narodí spravodlivosť podľa Tvojej vôle a nech ju žijem! Amen. Pieseň: ES 446 Autor: Pavol Trúsik Dbajte o to, aby ste zachovávali, čo vám prikázal Hospodin, váš Boh. Neodchyľujte sa ani napravo, ani naľavo! 5.Mojžišova 5,32 Ježiš hovorí: „Ak Mi niekto slúži, nech Ma nasleduje, a kde som Ja, tam bude aj Môj služobník.“ Ján 12,26 Jeremiáš 20,7-11 •  Modlíme sa za: Štítnik (GeS) Otázky na rozjímanie: Ako dnes žijem z istoty, že „Božie zákony sa podobajú olovnici“ — či som ochotný/áRecognizovať, že mojim životom je „krivý, pokrútený a nepodobný olovnici“, alebo som stále plný/á toho, že moje vychýlenia sú len „nepatrná odchýlka na začiatku“, ktorá sa čím ďalej, tým viac zväčšuje? Kde v mojom živote som ako Izrael, ktorý má „krivé, pokrútené“ životy — či som ochotný/á dať si do stredu olovnicu, aby som videl moje vychýlenia, alebo som stále plný/á ľahostajnosti alebo neláskavého zákonníctva? Ako dnes žijem z výzvou „Láska a spravodlivosť boli pre nás celkom prirodzeným vyjadrením nášho vzťahu k dokonalému Bohu“ — či som ochotný/á nechať Boha premieňať moje srdcia i myseľ, alebo som stále plný/á toho, že pre človeka je tým najprirodzenejším byť neprirodzený? Aplikácia do života: Dnes si spomeňte na jednu situáciu, kde ste boli „krivý, pokrútený“ (odklon do ľahostajnosti, neláskavého zákonníctva, neprirodzenosti). Napíšte si modlitbu: „Bože, ďakujem Ti, že nás duchovne narovnávaš! Odpusť, že mám niekedy radšej krivé chodníčky! Daj, nech sa vo mne narodí spravodlivosť podľa Tvojej vôle a nech ju žijem!“ Potom urobte jeden krok duchovného narovnania: konajte lásku (odpusťte niekomu, kto vás zraňoval), konajte spravodlivosť (pomôžte chudobnému, utláčenému), alebo čítajte Bibliu a modlite sa s úprimným srdcom. Dnes som vďačný za tieto 3 veci: ___________ ___________ ___________ Viac o vďačnosti, čo to je, prečo je dôležité byť vďačný, ako praktizovať vďačnosť nájdeš na blogu

This week, we're revisiting a previous conversation with Jon Koch, CEO, and Brian Lawrence, CFO and President, as they share their perspective on what's next for CTI as the organization enters a new phase of growth. They reflect on CTI's legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials.From scaling capabilities and investing in talent to strengthening operational discipline and embracing data-driven decision-making, Jon and Brian offer an inside look at how leadership alignment is shaping strategy. They also explore the evolving demands of the clinical research industry, from the need for predictability and site support to the practical application of technology and AI.At its core, this conversation is about balancing growth with purpose: delivering for sponsors, strengthening teams, and ultimately improving outcomes for patients.00:36 CTI Rewind: Revisiting CTI's leadership transition and future vision00:58 Expanding CTI's reach in complex and advanced therapy trials02:23 Disciplined growth strategy and sustainable global expansion04:38 CTI's legacy of care, credibility, and partnership06:14 Driving performance through metrics and accountability09:03 Leadership alignment and partnership in action12:13 Talent development, infrastructure, and AI enablement14:14 Positioning CTI for continued growth in complex trials17:12 Key industry trends: predictability, sites, and technology20:40 Sustaining culture and employee experience22:08 Long-term vision: scale, impact, and global presence25:15 Closing takeaways: quality, people, and execution

What does it take to design clinical trials that truly put patients first—especially when those patients are children?In this episode of Moving Medicine Forward, Dr. Radhika Peddinti, Medical Director at CTI, discusses her journey from pediatric hematology/oncology at the bedside to shaping clinical research at a global scale.Drawing on more than two decades of experience caring for children and their families, Dr. Pennant shares how those deeply human moments continue to influence how she approaches trial design today. From the emotional realities of pediatric oncology to the promise of gene therapies and targeted treatments, this conversation highlights the balance between scientific rigor and compassion—and why both are essential to advancing medicine.Together, they discuss how clinical trials can be designed to reflect real patient lives, the evolving landscape of rare disease research, and the leadership perspective required to make decisions that impact patients far beyond the clinic.If you're interested in the future of pediatric research, patient centered innovation, and what it truly means to move medicine forward, this episode is for you. 00:37 Meet Dr. Peddinti | Background in pediatric hematology/oncology and transition to CTI.01:17 Finding Her Path | From training in India to a career shaped by patient and family experiences.03:37 From Bedside to Research | Shifting focus to impact patients at a broader scale.04:00 The Reality of Pediatric Oncology | Challenges, resilience, and redefining normal for children and families.05:39 Expanding Impact Through Trials | Sickle cell research and the move into clinical development.07:33 Designing with Patients in Mind | Bringing real-life patient needs into clinical trial design.08:58 Balancing Science & Compassion | Why rigor and humanity are both critical to successful trials.09:30 Leadership Lessons | Showing up with honesty, empathy, and adaptability.10:47 The Future of Medicine | Breakthroughs in targeted therapies, gene therapy, and cure-focused research.13:15 Advice for Clinicians | You don't need to check every box—your experience matters.

Parce que… c'est l'épisode 0x311! Shameless plug 26 et 27 juin 2026 - leHACK 30 juin au 2 juillet 2026 - Pass the SALT 19 septembre 2026 - Bsides Montréal 20 au 26 septembre 2026 - BruCON 13 novembre 2026 - DEATHCon 16 au 19 novembre - European Cyber Week 1 au 3 décembre 2026 - Forum INCYBER - Canada 2026 24 et 25 février 2027 - SéQCure 2027 Description Introduction Cet épisode spécial, enregistré à Montréal lors de la conférence NorthSec, réunit Coline Chavane et Maxime Arquillière, venus de France présenter leur recherche sur l'ADINT (advertisement-based intelligence). Leur équipe CTI, spécialisée dans le suivi des fournisseurs privés de logiciels espions (spyware) et membre de l'initiative Pall contre les abus de ces technologies, a identifié cette tendance émergente en cherchant à documenter les nouveaux vecteurs d'intrusion utilisés par ces entreprises, au-delà des exploits « zero-click » déjà connus (comme ceux exposés par Citizen Lab ou Amnesty International sur WhatsApp). Comment fonctionne la publicité en ligne Coline explique le mécanisme du real-time bidding : en moins de 100 millisecondes, chaque fois qu'un espace publicitaire s'affiche dans une application, un système d'enchères se déclenche. Les données de l'utilisateur (type d'appareil, identifiant publicitaire mobile, centres d'intérêt) sont transmises à de multiples annonceurs qui enchérissent pour diffuser leur publicité. Fait crucial : même les annonceurs qui perdent l'enchère reçoivent ces données, sans qu'aucun contrôle ne soit possible sur leur usage ultérieur. Cet identifiant publicitaire mobile (MAID), censé être pseudo-anonymisé, permet en réalité un suivi cross-plateforme très précis, exploitable à grande échelle pour désanonymiser les individus. Maxime souligne que ce système est mondialement fragmenté par des cadres légaux disparates (RGPD en Europe basé sur l'opt-in, régimes opt-out ailleurs), créant des zones grises que certaines entreprises exploitent. Les trois catégories d'ADINT Les intervenants ont catégorisé les usages détournés de ces données en trois types : ADINT passif : collecte massive de données publicitaires (directement ou via des data brokers) pour établir des profils. Exemple donné : identifier les employés d'un site sensible (agence de renseignement, site de défense) en observant les téléphones qui s'y rendent quotidiennement, puis recouper avec leur domicile et leurs fréquentations pour du profilage. ADINT actif : au lieu d'observer passivement, l'acteur configure une alerte déclenchée dès qu'un identifiant mobile spécifique participe à une enchère publicitaire dans un périmètre donné, permettant un suivi quasi temps réel d'une cible précise. Ces données sont ensuite revendues à des gouvernements, forces de police ou entreprises privées. ADINT offensif : le plus préoccupant, il utilise le processus d'enchère lui-même comme vecteur d'intrusion, en délivrant une publicité vérolée à une cible spécifique pour compromettre son appareil. Documenté notamment par Amnesty International dans les dossiers Intellexa, ce vecteur « stratégique » complète les vecteurs « tactiques » nécessitant une proximité physique. Un écosystème sophistiqué et concentré Maxime explique que cette diversification des vecteurs d'intrusion est stratégiquement vitale pour les fournisseurs de spyware, surtout après la condamnation de NSO Group aux États-Unis lui interdisant de cibler WhatsApp — une décision qui menace la viabilité économique d'entreprises dépendantes d'un vecteur unique. Fait notable révélé par Recorded Future : au sein du consortium lié à Intellexa figure une entreprise publicitaire propriétaire d'un SSP (plateforme utilisée par les éditeurs d'applications), directement intégrée au processus d'enchères. Cela confirme que l'ADINT offensif reste réservé à des acteurs sophistiqués et bien financés, souvent israéliens ou américains, employant d'anciens membres de services de renseignement en cyberintrusion. Ces sociétés se déploient notamment en Asie, marché en expansion, comme l'ont découvert Coline et Maxime via des brochures commerciales trouvées en source ouverte — notamment celles de la société « Patterns », qui vante la désanonymisation à partir d'un simple numéro de téléphone. Usages à grande échelle et actualité Interrogés sur des attaques plus larges que le ciblage individuel, les invités distinguent l'ADINT du malvertising (opportuniste et large). Ils citent toutefois un cas documenté en Syrie (2015-2016) où le ciblage publicitaire a servi à comptabiliser et suivre les déplacements de réfugiés fuyant une zone de guerre. Plus actuel : aux États-Unis, l'agence ICE figure parmi les clients confirmés de solutions incluant des capacités ADINT — une utilisation désormais assumée publiquement, contrairement à des pratiques plus discrètes par le passé. Protections limitées pour les utilisateurs Coline note que certaines initiatives existent côté fabricants (comme le Lockdown Mode d'Apple, limitant les permissions de suivi GPS), mais que les utilisateurs disposent de peu de moyens concrets au-delà de l'hygiène numérique de base (refus des cookies, etc.) pour se protéger de ce profilage à grande échelle. Conclusion Cette recherche met en lumière un angle mort de la surveillance numérique : un écosystème publicitaire légitime, mondial et extrêmement efficace pour capter des données comportementales, détourné par une industrie grise et bien financée à des fins de renseignement, de profilage et, dans les cas les plus sophistiqués, d'intrusion informatique ciblée. Notes Sold to the highest bidder - the escalation of ADINT from geolocation tracking to intrusion vector Collaborateurs Nicolas-Loïc Fortin Maxime Arquillière Coline Chavane Crédits Montage par Intrasecure inc Locaux réels par Northsec

On today's CTI, Andy and DJ break down the latest developments as U.S. and Iranian officials conclude a second round of talks in Switzerland aimed at a broader agreement, an anti-ICE protester waving an upside-down American flag is struck by a vehicle outside Delaney Hall, and Rory McIlroy goes viral after brutally shutting down a heckler during the U.S. Open in New York.

Back on Episode 247.5 Pat gave an overview of Creed Taylor's famous (infamous?) CTI label that bestrode the first half of the nineteen seventies like a jazz colossus. Now we've got both members of the 'cast weighing in on four of the label's better productions. So comb your sideburns (and your shag rugs) and settle in for a discussion of the best jazz-oriented baby-making label of the first half of the "me" decade. Milt Jackson – SUNFLOWER; Antonio Carlos Jobim – STONE FLOWER; Joe Farrell – OUTBACK; Airto – FREE.

In this episode, we're joined by Rafael Miñana Prieto, Senior Manager of Operations for Laboratory Services at CTI, who oversees global biorepository operations across the U.S. and Europe. He walks through the full specimen lifecycle—from kit design and sample collection to storage, retrieval, and delivery—and explains why biological specimens are the foundation of clinical research. Rafael shares how consistent, end-to-end management, global standardization, and integrated laboratory services help protect data integrity, reduce risk, and improve outcomes across trials. He also highlights how small upstream decisions can impact downstream results, along with the operational challenges and evolving trends shaping modern biorepository services. 01:26 Rafael's role and the end-to-end specimen lifecycle02:15 Why sample integrity underpins clinical evidence and patient impact03:26 Lifecycle complexity and global logistics challenges04:16 Standardization, monitoring, and risk reduction strategies05:32 Coordinating retrieval and global shipment06:31 Upstream decisions (kit design, instructions) shaping outcomes07:23 Integrated lab services and reduced fragmentation07:59 Scaling challenges and pre-analytical gaps09:24 Key trends: complexity, globalization, and data-driven operations10:07 CAP accreditation and delivering consistent global standards

A Kibertámadás! 111. epizódjában a deepfake jelenség kerül a középpontba. Vendégünk Dr. Veszelszki Ágnes kommunikáció kutató, az NKE Nemeskürty István Tanárképző Karának dékánja, aki Tamással arról beszélget, mit jelent a deepfake fogalma, hogyan kapcsolódik a mesterséges intelligenciához, és milyen formái vannak a videó-, hang- és kép manipulációnak. Szó esik ismert deepfake-esetekről, a dezinformációról, valamint arról is, miért válik egyre nehezebbé eldönteni, hogy egy online tartalom hiteles-e. Az adás bemutatja a „három T” módszert: Tartalom, Technológia, Terjesztő, amely segíthet tudatosabban vizsgálni a gyanús tartalmakat. A beszélgetés végső tanulsága, hogy a digitális világban a biztonság egyik alapja a médiatudatosság, a kontextus értelmezése és a kritikus gondolkodás. A DeepFake-ről készült CTI elemzésünket az alábbi linken tekintheti meg: https://nki.gov.hu/it-biztonsag/elemzesek/szorakozastol-a-jogsertesig-hogyan-hasznalo-a-deepfake/

What does a recovering clinical research market actually look like in 2026?In this episode, Joel White, Owner of Market Cap Consulting, and Ryan Gifford, Vice President, Global Laboratory Services, Business Development & Client Management at CTI, join us to unpack the state of the industry—from the rebound in biotech funding to the growing importance of execution, site relationships, and smarter trial design.We explore how increasing complexity is shaping partnerships, how labs and decentralized models are evolving, and what it will take to keep trials on track. Looking ahead, the conversation offers a practical perspective on what the next 12–18 months could bring. 01:00 Guest backgrounds: Joel White (Market Cap Consulting) and Ryan Gifford (CTI) 02:45 Market recovery and funding trends05:15 Trial success: early collaboration and site relationships08:15 Funding challenges and execution impacts 10:30 Reducing site burden through lab operations and logistics 14:15 Decentralized trials and patient experience16:25 Regulatory shifts, AI, and growing data complexity19:30 Future outlook: partnerships and global trial expansion 23:30 Key takeaways and rapid-fire insights

We talk to Bill Fons, President of AI Initiatives at CTI about the AVIXA AI Accelerator panel during the show. We also discuss the many other AI-centric discussions and roundtables that will be a part of the show, and how this technology is evolving to suit the needs of integrators in many different verticals.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Jon Koch, CEO, and Brian Lawrence, CFO and President, share their perspective on what's next for CTI as the organization enters a new phase of growth. They reflect on CTI's legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials.From scaling capabilities and investing in talent to strengthening operational discipline and embracing data driven decision-making, Jon and Brian offer an inside look at how leadership alignment is shaping strategy. They also explore the evolving demands of the clinical research industry, from the need for predictability and site support to the practical application of technology and AI.At its core, this conversation is about balancing growth with purpose: delivering for sponsors, strengthening teams, and ultimately improving outcomes for patients. 00:35 CTI leadership transition and future focus01:23 Expanding reach in complex and advanced therapy trials02:48 Disciplined growth strategy and global expansion05:03 CTI's legacy of care, credibility, and partnership06:39 Driving performance through metrics and accountability09:28 Leadership alignment and partnership in action12:38 Talent development, infrastructure, and AI enablement14:38 Positioning for growth in complex trials17:37 Key industry trends: predictability, sites, and tech21:05 Sustaining culture and employee experience22:33 Long-term vision: scale, impact, and global presence25:39 Closing takeaways: quality, people, and execution

In this episode of Unspoken Security, host AJ Nash sits down with Dan O'Day, Senior Consulting Director at Unit 42 by Palo Alto Networks. Dan shares key findings from the 2026 Global Incident Response Report, built from over 750 real-world cyber incidents, covering four major threat trends reshaping the security landscape.Dan breaks down how AI is compressing attack timelines at a dramatic rate. The fastest incidents now move from access to full impact in just 72 minutes, down from 285 minutes the year prior. Attackers are no longer breaking in. They are logging in, using stolen credentials, tokens, and API keys to move laterally and avoid detection. Identity is now the dominant attack surface, playing a material role in nearly 90% of Unit 42's investigations.The conversation closes on a note of cautious optimism. Dan argues that over 90% of breaches stem from preventable gaps, meaning security is solvable. He outlines three priorities for defenders: empowering the SOC to act at machine speed, treating identity as the new perimeter, and securing the entire software supply chain from the first line of code to cloud runtime.Download the Unit 42 Global Incident Response Report 2026 here: https://www.paloaltonetworks.com/resources/research/unit-42-incident-response-report?utm_source=linkedin&utm_medium=social&utm_campaign=na&utm_content=pa001134 Send us Fan MailSupport the show

¿Puede un virus ser la cura?En esta entrevista, los reconocidos científicos uruguayos Pilar Moreno y Gonzalo Moratorio nos cuentan cómo su startup, Guska, está transformando a los virus en "aliados" para combatir los tumores más agresivos. Pero lo que comenzó como una investigación de vanguardia, se convirtió en una carrera armamentista por la vida cuando el propio Gonzalo recibió un diagnóstico inesperado.La ciencia detrás de GuskaA través de la ingeniería genética, el equipo de Guska reprograma el material genético de virus que normalmente causan enfermedades leves para que tengan una función dual: infectar y destruir células tumorales sin dañar las sanas, y actuar como una señal que "despierta" al sistema inmune para que ataque el tumor. Es ciencia de frontera que hoy integra herramientas como la Inteligencia Artificial para decodificar tumores y acelerar los tiempos hacia una cura.Un giro que lo cambió todoLa investigación, que inicialmente se centraba en cáncer de pulmón y páncreas, dio un vuelco total tras el diagnóstico de glioblastoma (un tumor cerebral agresivo) de Gonzalo. Desde la cama de un CTI, la misión de Guska se volvió personal: el equipo redirigió sus esfuerzos hacia los tumores del sistema nervioso central, trabajando sin descanso desde el primer día para encontrar soluciones.Esperanza y futuroCon una meta clara de llegar a ensayos clínicos en humanos en un plazo de 2 a 3 años, Gonzalo y Pilar nos demuestran que la ciencia se alimenta de la pasión y la resiliencia. Gonzalo comparte su optimismo inquebrantable, impulsado por el deseo de estar presente en los momentos más importantes de la vida de su hija, apoyándose en lo que más conoce: la investigación científica y la fe ciega en su equipo.

La tensión en Colombia alcanza un nuevo nivel. El ELN ha llevado a cabo un polémico "juicio revolucionario" contra agentes del CTI y la DIJIN, un acto que ha generado indignación y pone en entredicho toda la política de Paz Total del gobierno de Gustavo Petro.¿Qué significa esta acción para el futuro de las negociaciones y la seguridad del país?  Los invitamos a seguir el canal de SinCandado en WhatsApp. Activen la campanita.   Visite nuestras cuentas en X (Twitter), Instagram, Youtube y Youtube Music y el podcast de SinCandadoRadio en Spotify y demás plataformas   Ampliación de esta noticia en sincandado.com

Dr. Robert Wagner, Senior Medical Director and Principal Investigator at CTI's Clinical Research Center, shares more about clinical trial operations at research sites.  Reflecting on nearly three decades in internal medicine and hospital‑based care, Dr. Wagner shares his path from patient care into clinical research, how that experience shapes his approach as an investigator, and why strong research sites are critical to trial quality and outcomes. The conversation also touches on the day‑to‑day realities of running trials and how site operations, technology, and patient‑centered practices continue to evolve. 01:00 His past experiences and current role as a Principal Investigator at CTI.03:00 How clinical experience shaped his transition into research.05:30 Daily responsibilities and the importance of sites.08:30 Technology, recruitment, and patient access.10:45 Guidance for physicians and patients; the future of clinical research.

In this episode of Unspoken Security, host A.J. Nash sits down with Cynthia Kaiser, SVP at Halcyon's Ransomware Research Center. They explore how ransomware grew from a niche crime into a business, and why security teams now face faster attacks, extortion, and a threat landscape that blurs crime and state activity.Cynthia traces the shift from early encryption schemes to double and triple extortion, then explains how professional crews use access brokers, deepfakes, and AI-assisted phishing to move in hours, not weeks. She also breaks down how Russian-speaking groups, Iranian actors, and state-linked operations use cybercrime for profit, cover, and pressure.She argues that defenders still need the basics: harden identity, patch fast, assume breach, and build response plans that include PR. Cynthia closes with a blunt point: ransomware and fraud are not side issues. They hit hospitals, businesses, and families every day in ways nation-state threats often do not.Send us Fan MailSupport the show

Halle Raicevich, Research Associates Manager; Rick Renko, Project Manager, Regulatory & Scientific Affairs; and Alexa Kehoe, Senior Clinical Project Coordinator, are featured on this episode of the Moving Medicine Forward podcast to discuss CTI's Research Associate (RA) Program. This pathway is designed to help emerging talent gain real‑world experience while exploring opportunities across the industry. Tune in to explore the value of mentorship and early exposure for professionals beginning their careers and learn how CTI's people‑first culture supports growth at every stage.00:51 Meet the guests: Halle Raicevich, Ricky Renko, and Alexa Kehoe01:23 Overview of the RA program and its role as an entry point into clinical research03:00 Why CTI invests in early‑career development and hands‑on learning04:08 How cross‑department exposure builds confidence and strengthens collaboration04:49 A typical day for a Research Associate05:57 Skills gained through the RA role07:06 The importance of flexibility and mentorship08:20 How the RA program supports long‑term career growth across functions09:18 Expanding the RA program internationally and lessons learned from global implementation10:56 Developing future leaders through mentorship12:23 Advice for those considering the RA program or a career in clinical research14:27 Community involvement and CTI's people‑first culture16:37 Why the program is a powerful career foundation

In episode 185 of Cybersecurity Where You Are, Sean Atkinson sits down with Brian Calkin, Chief Technology and Innovation Officer at the Center for Internet Security® (CIS®); Theodore "TJ" Sayers, Senior Director of Threat Intelligence at CIS; and Kyle Leonard, Cyber Threat Intelligence Analyst at CIS. Together, they use a risk perspective to discuss artificial intelligence (AI) prompt injection and how to defend against it.Here are some highlights from our episode:00:49. A definition of AI prompt injection for businesses and executives02:16. Brian on his role of guiding AI implementation at CIS03:12. Understanding the urgency surrounding AI prompt injection as a security risk05:32. Signals and trends indicative of threat actors attempting to weaponize prompt injection07:10. How AI prompt injection differs from traditional input validation vulnerabilities11:13. Early indicators that cyber threat intelligence (CTI) teams can monitor15:00. The need to treat AI as a new identity in any enterprise implementation strategy17:10. Understanding the difference: AI safety vs. AI security20:36. Foundational, practical AI security that extends across all sectors24:55. How CIS manages risk and supports the opportunity around the use of AI28:25. The long-term promise of AI-driven vulnerability discovery grounded in fundamentals34:48. Recommendations for piercing through the marketing hype surrounding AIResourcesPrompt Injections: The Inherent Threat to Generative AINew CIS Report Warns Prompt Injection Attacks Pose Growing Risk to Generative AIEpisode 182: Striking a Balance on an AI Adoption JourneyEpisode 120: How Contextual Awareness Drives AI GovernanceMythos AI: What Actually Matters for Cybersecurity LeadersApplying the CIS Controls to Real‑World AI EnvironmentsAn Examination of Generative AI and Physical Threat PlanningAI Playbooks for SLTT Cybersecurity LeadersIf you have some feedback or an idea for an upcoming episode of Cybersecurity Where You Are, let us know by emailing podcast@cisecurity.org.

Vincent Drouillon, Vice President of Global Central Lab Strategy and Growth at CTI, discusses how central laboratory services support clinical trials. He shares his path into laboratory medicine, explains why early collaboration and partnership are key to trial success, and outlines how global alignment and integrated lab solutions help sponsors move medicine forward. 00:36 Overview of Vincent's role and background in laboratory medicine and clinical research.01:18 Vincent's career path and what drew him to central laboratory services.02:37 The global impact of central labs and their role in developing new medicines.03:44 Why global collaboration and diverse perspectives matter in central lab work.04:28 Recognizing laboratory professionals and the importance of Lab Week.05:26 Leading growth, scalability, and strategy for CTI's central lab services.06:55 How CTI's quality-focused, flexible, and holistic approach differentiates its lab services.07:54 Supporting complex and integrated clinical trials across specialized therapeutic areas.09:29 Why lab planning and logistics are often underestimated in trial design.11:19 The value of early engagement to reduce risk and prevent downstream delays.14:39 Emerging capabilities shaping the future of laboratory services, including AI, analytics, and personalized medicine.17:12 Closing reflections on partnership, patient impact, and the role of laboratories in moving medicine forward.

Shakirah Bradford, Senior Director of Vendor Management and Sourcing at CTI, discusses the key relationships that support clinical research. She also shares her unconventional path into sourcing and highlights why vendor management is uniquely complex within regulated environments. Since joining CTI, Shakirah has helped shift vendor relationships from transactional to strategic, equipping teams with the partnerships and tools needed to move medicine forward.  00:33 Overview of Shakirah's role and cross industry background in vendor management. 01:25 How relationship building led Shakirah into sourcing and vendor management. 03:09 Selecting, contracting, and overseeing third-party vendors across the organization. 04:00 A housebuilding analogy to explain the role in everyday terms. 04:42 The impact of global regulations and quality requirements on vendor oversight. 05:31 How trust and long-term relationships improve execution and efficiency. 06:47 What defines true partnerships in clinical research. 07:52 Shakirah's evolving approach to collaboration and stakeholder needs. 08:37 Why creativity, curiosity, listening, and asking questions matter. 09:32 Choosing an industry you're passionate about and staying connected to patient impact. 11:17 Final reflections on passion and partnership.  

(Presented by TLPBLACK: A cybersecurity intelligence platform focused on sharing curated, high-sensitivity threat insights and research with trusted security professionals.) Three Buddy Problem - Episode 93: We discuss Anthropic's release of Claude Mythos Preview (an AI model so capable and dangerous they won't release it publicly) and debate the looming patching crisis, bug bounty extinction, possible US government nationalization of frontier labs, and why the NSA might not be thrilled about all this bug-fixing. Plus, North Korea's six-month Drift Protocol con job, APT28's retro DNS hijacking campaign, and Microsoft's driver signing mess hitting WireGuard and VeraCrypt. Cast: Juan Andres Guerrero-Saade, Ryan Naraine and Costin Raiu. 00:00 — Opening banter 01:36 — Anthropic Mythos Preview + Project Glasswing 06:17 — USG reaction + Wall Street emergency meeting 10:54 — Mythos capabilities vs hype (technical reality check) 13:44 — PR stunt? Skepticism of Anthropic narrative 20:42 — The patching crisis + “defender advantage” 27:41 — Bug bounty model under threat from AI 33:37 — Mythos practical workflows 45:09 — Geopolitics, NSA angle, and nationalization discussion 01:40:18 — Fortinet zero-day + ongoing failures 01:42:39 — Drift Protocol heist ($285M) + long-term social engineering 01:44:07 — Revisiting XZ Utils / Jia Tan attribution 01:54:07 — Crypto security gaps + need for real CTI in blockchain 02:04:22 — APT28 DNS hijacking + router compromise campaign 02:18:57 — Microsoft driver signing meltdown + ecosystem impact

In this episode of Unspoken Security, host A.J. Nash sits down with Erin West, Founder at Operation Shamrock. They explore the “scamdemic” and the scams draining wealth at industrial scale. Erin explains why business email compromise, government impersonation, and romance scams work so well: they use fear, trust, urgency, and loneliness.She then breaks down pig butchering, a long con that starts with a stray text and grows into a fake relationship and a fake crypto investment. Victims think they are building love and wealth at the same time. Instead, scammers push them to empty savings, tap retirement accounts, and borrow more.Erin also exposes the system behind the fraud. Many scammers are trafficking victims forced to work inside compounds in Cambodia, Myanmar, and beyond. She argues this is both a financial crime and a human rights crisis, and she calls for stronger reporting, public awareness, and international pressure.Send us Fan MailSupport the show

What drives success at a clinical research site?Adam Roth, VP of Research Site Services, and Nick Finan, Director of Business Development and Client Management, share insights on site operations at CTI's Clinical Research Center. They discuss feasibility, patient experience, trust based partnerships, and why operational realism is key to delivering high-quality clinical trials. Throughout the conversation, Adam and Nick also explain how strong collaboration among sites, sponsors, and CROs ultimately drives better outcomes for patients.  01:00 Adam Roth and Nick Finan share their roles supporting site operations and sponsor partnerships at CTI.02:30 An overview of day-to-day site operations and resourcing throughout all phases of clinical trials.04:00 How feasibility, therapeutic expertise, and operational readiness guide trial selection.06:00 Why understanding patient and staff realities leads to better‑designed, better‑executed studies.09:30 Building long‑term relationships through honest conversations about consistency and delivery.11:00 How CTI preserves ethical boundaries while supporting productive collaboration.13:00 Using site experience to improve CRA training and organizational best practices.16:00 Why the strongest sponsor, CRO, and site relationships are built on shared goals.20:45 Reflections on teamwork, trust, and moving medicine forward together.

In this episode, I'm joined by returning guest Jeff Copper, a cognitive engineer, ADHD coach, and host of Attention Talk Radio. Jeff has been a long-time voice in the ADHD community, and today we dive into a fascinating conversation about motivation, emotion, and executive function in ADHD.Together, we explore a completely different way to think about motivation. Instead of seeing ADHD as a lack of motivation, Jeff introduces a powerful framework that explains why motivation can feel so difficult—and how the right accommodations can completely change the game. We also discuss the emotional cost of executive functioning, why “lazy” isn't a useful label, and how collaboration and conversation can unlock productivity for ADHD brains. If you've ever wondered why some tasks feel impossible while others feel effortless, this episode will give you a fresh lens to understand it.Episode Highlights[0:42] - Introducing returning guest Jeff Copper and his work in cognitive ergonomics[2:41] - What motivation really is and why it's deeply tied to emotion[4:39] - Situational variability: why ADHD brains may choose TikTok over taxes[7:32] - Why the word “lazy” doesn't belong in conversations about ADHD[9:00] - The two-force model of motivation: automatic brain vs. executive functioning brain[15:02] - How executive function impairment changes the effort required for motivation[17:05] - Why willpower and rewards often fail as long-term ADHD strategies[18:49] - The problem with “extra time” accommodations and what might work better[20:30] - Why direct oral conversation can be a powerful ADHD accommodation[24:30] - The hidden role of collaboration in productivity and problem solving[30:11] - A real example: using conversation to get started on something like taxes[36:46] - How talking through problems strengthens executive function[42:15] - Are people with ADHD verbal processors?[45:01] - The big takeaway: ADHDers aren't unmotivated—they just need the right accommodations[47:25] - Thinking partners vs. accountability partnersLinks & ResourcesJeff Copper, cognitive engineer and ADHD coach, is founder of DIG Coaching Practice and host of Attention Talk Radio and Video. He developed Cognitive Ergonomics from the Inside Out ® , a new ADHD intervention using an engineering approach to address executive function challenges. Jeff holds an MBA from the University of Tampa and credentials from ICF, PAAC, ADDCA, and CTI. A member of ADDA, ACO, CHADD, PAAC, and ICF, he received ACO's 2022 Professional Excellence Award. His work continues to innovate and redefine ADHD coaching through practical insights and a focus on how minds truly work.Jeff Copper – DIG Coaching - digcoaching.comAttention Talk Radio - attentiontalkradio.comAttention Talk Video - attentiontalkvideo.comAttention Talk News - attentiontalknews.com

Today is an update on 2 of our brilliant guests and the powerful art they are putting out into the world. In episode 128 we interviewed Kristin Marrs and Anne Marie Nest about a theatre/dance piece they created called Chalk, which is about both of their journeys through miscarriage and infertility. These amazing women have been busy in the last year because they developed the piece into a full length show that opened in Denver last weekend, and will open in Iowa City for 4 shows at the James next weekend, March 21-24. Tickets can be found at http://www.thejamesic.com. In today's episode we: Hear about how Anne Marie & Kristin met during their challenges with infertility and multiple miscarriages, and how this eventually led to creative collaboration and birthing of a new piece of art. The process of creating this piece, and the magic of how it all came together when they set the intention of “this can be easy”. Ancestral patterning, and stories of women that came before Anne Marie and Kristin that had challenges with child bearing. The infertility journey that both women experienced,  including all the ups and downs, the limits of the medical system, and the deep, hidden grief and shame. Why the topic of infertility and miscarriage has been so  “silenced” in our culture. Why we need these stories more than ever in our current political arena when so many women are having challenges receiving the health care they need. Bios: Iowa native Kristin Marrs is a dancer, choreographer, and movement teacher. She is an Associate Professor of Instruction and Director of Graduate Studies at the University of Iowa Department of Dance, where she teaches a wide variety of courses across the dance and somatic curriculum. She is also a certified Alexander Technique teacher, and has a private studio in Iowa City where she works with students of all ages and abilities in improving alignment, breathing, postural tone, and ease of movement. She is a proud mama of two kids.  www.kristinmarrs.com Anne Marie Nest-Pinero met Kristin at the University of Iowa while she was professor of voice and speech in the Theater Department. Prior to her career in academia, Anne Marie was a professional actor, working primarily in regional theaters and Shakespeare Festivals.  Anne Marie now works as an executive coach and communications consultant for the Fortune 500 and AM Law 200.  She is an Associate Teacher of Fitzmaurice Voicework, trained mediator through Columbia University, and certified CTI coach. www.annemarienest.com Past Episodes You Might Like About Women's Health, Medical Systems & Well-Being   Episode 122:  Nina Lohman: The Body Alone: A Lyrical Articulation of Pain Episode 105: Kate O'Donnell: Ayurveda for Women's Health Episode 99: Cate Stillman: The Witch's Cancer Journal  Episode 88: Sam Ferm-LeClere: Healing with Chronic Illness Episode 37: Can We Trust Other Women and Their Bodily Autonomy Seasoned Wisdom Date: April 1st, 11am – 1pm Come soak up the wisdom that only comes from age…A signature event of the Water Bearer Collective in partnership with the Tend HER Wild Podcast. Join the Water Bearer Collective in partnership with Tend HER Wild Podcast hosts Dr. Betsy Rippentrop and Kate Moreland, for a special live podcast event, “Seasoned Wisdom.” This intimate and powerful conversation will feature 4 legendary older women who are overflowing with unapologetic authenticity, hard-won insight, and deep self-trust and wisdom that only comes with age. Event Details: This event will be held at the James Theatre, Iowa City on April 1st from 11am – 1pm. A light lunch will be served and time to network will follow the recording. REGISTER HERE Today's Episode sponsored by: The Local Hub (https://thelocalhub-ic.com/) Kate Moreland Coaching (https://www.katemorelandcoaching.com/) Dr Yoga Momma (https://dryogamomma.com/) Heartland Yoga (https://heartlandyoga.com/) Want to go on retreat? Want to join Betsy in Costa Rica in May 11-18 2026 at her favorite retreat center to help you connect with your inner healer using yoga, meditation, energy medicine, and creativity?  At this retreat, broadway director Kristin Hanggi is joining to lead on the power of creativity to move us through our collective and personal anxiety.   All the details here! Source

In honor of World Kidney Day, we're rereleasing this timely and insightful episode of Moving Medicine Forward. In this conversation, we sit down with Dr. Helio Tedesco, a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world's largest kidney transplant programs and is now part of the CTI team. Joined by Dr. Christopher Boshkos, Senior Medical Director at CTI, and clinical scientist Erika Aldag, the discussion explores the challenges and innovations behind managing more than 15,000 transplant patients—from telehealth expansion and donor matching to cutting-edge immunosuppressive strategies and the future of surveillance tools such as cell-free DNA and the iBox model. This episode offers a rare look into the science, systems, and human dedication driving transplant care forward. 00:35 Dr. Helio Tedesco (São Paulo), Dr. Christopher Boshkos, and Clinical Scientist Erika Aldag join to discuss global kidney transplant practices. 01:13 Dr. Tedesco shares his background, highlighting nearly 40 years in nephrology, performing over 1,000 kidney transplants annually, and a strong foundation in research. 03:17 Managing large transplant populations involves strategic follow-up care, decentralized nephrology networks, and an expanding role for telehealth. 06:30 How patients are matched to regimens, minimizing rejection and addressing regional challenges. 11:49 Dr. Tedesco explains their one-dose thymoglobulin approach and its benefits over traditional multi-dose methods. 18:34 New tools for monitoring graft health include donor-derived cell-free DNA, advanced biopsy techniques, and an examination of barriers to widespread adoption. 24:25 Discussion on the potential of the iBox model as a predictive tool for clinical trials and long-term graft survival. 28:15 Transplant science is headed toward improved long-term therapies, innovative biologics, and more patient-friendly immunosuppression options. 32:15 Successes and learnings from scaling telehealth to support a large patient base. 37:41 Appreciation for the collaboration between CTI and global transplant centers.

Neste episódio do Pura Connection, André Bintang recebe Antonio Assef, o “Dr. Porrada”, médico, faixa preta, atleta de ADCC e especialista em medicina esportiva e hormônios para lutadores e praticantes de Jiu-Jitsu.Ele conta como saiu dos 180kg, voltou a competir em alto nível e transformou o próprio corpo em laboratório para entender sono, alimentação, musculação, reposição hormonal e longevidade. Fala sem rodeios sobre hormônios x “bomba”, peptídeos, estresse, queda de testosterona em jovens, ansiedade, depressão e o impacto da vida moderna na saúde.Entre histórias de CTI e Covid, filosofia de derrota (“ou você aceita que é frouxo ou volta mais forte”) e preparação para o ADCC na maturidade, o episódio conecta Jiu-Jitsu, medicina, espiritualidade, estilo de vida e inteligência da vida.Uma conversa afiada e profunda para quem quer viver mais, melhor e com o corpo preparado para o caminho marcial.

This week we are joined by Marcelle Lee, cybersecurity consultant and researcher, discussing "CTI tradecraft: Investigating a mobile scareware campaign." She details how a routine click on a Google News story led to a mobile scareware pop-up—and a deeper investigation into a broader campaign. Using free tools like Censys, URLScan, VirusTotal, and CyberChef, she pivoted from two domains to uncover more than 100 related domains, shared infrastructure, and links to questionable antivirus apps in the Google Play Store. The findings are mapped to the MITRE ATT&CK framework, showing how freely available resources can power meaningful, actionable threat intelligence. The research can be found here: ⁠CTI tradecraft: Investigating a mobile scareware campaign Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we are joined by Marcelle Lee, cybersecurity consultant and researcher, discussing "CTI tradecraft: Investigating a mobile scareware campaign." She details how a routine click on a Google News story led to a mobile scareware pop-up—and a deeper investigation into a broader campaign. Using free tools like Censys, URLScan, VirusTotal, and CyberChef, she pivoted from two domains to uncover more than 100 related domains, shared infrastructure, and links to questionable antivirus apps in the Google Play Store. The findings are mapped to the MITRE ATT&CK framework, showing how freely available resources can power meaningful, actionable threat intelligence. The research can be found here: ⁠CTI tradecraft: Investigating a mobile scareware campaign Learn more about your ad choices. Visit megaphone.fm/adchoices

Christin Godale, Executive Director of LifeSciKY, and Savannah Doliboa, Chief Commercial Officer at CTI and LifeSciKY board member, explore how purpose built infrastructure can unlock the next generation of medical breakthroughs in our latest podcast episode.Together, they discuss why infrastructure is often the missing link in drug development, how regional collaboration fuels innovation, and what success looks like when companies outgrow the incubator and scale locally. The conversation also shows the human side of ecosystem building by focusing on investing in people, nurturing talent, and turning scientific breakthroughs into real world impact.LifeSciKY is a mission driven hub designed to lower barriers for startups, accelerate early research, and strengthen Northern Kentucky's biotech ecosystem. Through affordable wet lab space, shared equipment, workforce development, STEM education, and community partnerships, it gives innovators the support they need to move discoveries from bench to patient.00:30 An overview of LifeSciKY as a mission driven life sciences hub supporting early stage innovation.01:45 Christin and Savannah share the vision behind LifeSciKY and how it benefits the region.04:00 How the lack of wet lab space stalled regional growth and why infrastructure is essential to moving medicine forward.06:45 Who LifeSciKY Is built for: startups, hybrid AI companies, and entrepreneurs looking to turn science into viable products.08:25 What success looks like for biotech, including formation, fundraising, and scaling beyond the incubator.10:15 How connecting academia, hospitals, industry, and government is building a regional life sciences ecosystem. 12:20 Affordable access, nonprofit mission, and hands on support sets LifeSciKY apart from other incubators.14:20 How multiple years of state support and leadership brought LifeSciKY to its grand opening.18:10 Workforce development and STEM outreach are building the next generation of life sciences talent.22:00 The future of LifeSciKY and why Northern Kentucky could become a biotech hub.23:10 Highlighting a LifeSciKY company developing more accessible CAR T therapies for children.25:00 Ways founders, students, and community members can engage with LifeSciKY.26:10 Reflections on momentum, mission, and future therapies.28:05 In their closing thoughts, Christian and Savannah explore excellence and growth.

Today we're talking to Jelena Radonjic, an award-winning career and leadership coach, who has coached 350+ clients worldwide, empowering them to thrive in the careers they love. With 25+ years in global recruitment and business education management, including MBA and EMBA careers, Jelena works with senior and mid-career professionals helping them achieve an average of 38% annual compensation increase, in in addition to career alignment and fulfillment. Through her powerful blend of career, business and leadership coaching coupled with transformational coaching, Jelena has elevated careers of global talent from Amazon, Uber, eBay, Siemens, HSBC, Goldman Sachs, BP, AstraZeneca, Diageo, Vodafone, Accenture, Deutsche Bank, GSK, The Cabinet Office, and many others.A CTI qualified coach, Jelena has worked with thought leaders such as Deepak Chopra and John Demartini, she is a Forbes Coaches Council member, speaker, and author. Having lived and worked in 3 countries, including Japan, she is multilingual and culturally sensitive. She is passionate about the Future of Work, Equity, Diversity and Inclusion and partners with individuals and organisations to create improved work life outcomes.Connect with Jelena:www.whatwork.co.uk  Jelena & What Work Career Coaching https://whatwork.co.uk/career-fitness-quiz/  Career Fitness Quiz - get a personalised report on the level of your Career Fitness!https://www.linkedin.com/in/jelena-radonjic-careerandleadership-coach/  Follow Jelena on LinkedIn to gain unique insights into the world of careers, and subscribe to her Career Growth Lane newsletter on LinkedinWhat resonated most with you?DM me on IG www.instagram.com/liveintechnicolor_If you enjoyed this episode, follow the podcast and leave a review! Remember - you're amazing and thank you for being here!Love, BaibaSupport the show

When follow-through keeps breaking down, the answer isn't planning harder. In this episode with ADHD coach Jeff Copper, we unpack why executive function struggles come from ambiguity, not lack of effort, and why direct conversation is a powerful accommodation. Press play to learn what actually helps kids and adults with ADHD move from planning to action.What to expect in this episode:Why people with ADHD struggle to execute plans even when the goal is clearHow ambiguity, not laziness, disrupts follow-through and problem-solvingWhat executive functions really are and how they operate as cognitive toolsThe power of direct conversation for improving clarity, focus, and emotional regulationADHD accommodations that are practical and often hide in plain sightAbout Jeff CopperJeff Copper, cognitive engineer and ADHD coach, is founder of DIG Coaching Practice and host of Attention Talk Radio and Video. He developed Cognitive Ergonomics From the Inside Out™, a new ADHD intervention using an engineering approach to address executive function challenges. Jeff holds an MBA from the University of Tampa and credentials from ICF, PAAC, ADDCA, and CTI. A member of ADDA, ACO, CHADD, PAAC, and ICF, he received ACO's 2022 Professional Excellence Award. His work continues to innovate and redefine ADHD coaching through practical insights and a focus on how minds truly work. Connect with JeffWebsite: DIG Coaching PracticeInstagram: @dig.coachingFacebook: DIG Coaching PracticeX: @digcoaching Related Links: EP92: Pushing the Reset Button to Solve Problems Collaboratively https://impactparents.com/solve-problems-collaboratively/ EP138: How Do I Get My Kids to Talk To Me? 4 Communication Tools https://impactparents.com/child-communication-tools/ EP172: Parenting Paradox: Avoid ‘Fix-It Mode' for Better Problem-Solving https://impactparents.com/avoid-fix-it-mode-parenting/ EP207: Rebuilding Trust with Teens: Cleaning the Slate Conversations https://impactparents.com/rebuilding-trust-with-teens-cleaning-the-slate-conversations/Get your FREE copy of 12 Key Coaching Tools for Parents at https://impactparents.com/podcastgift Connect with Impact Parents:Instagram: https://www.instagram.com/impactparentsFacebook: https://www.facebook.com/ImpactParentsLinkedIn: https://www.linkedin.com/company/impactparentsSponsors"Cognitive Ergonomics from the Inside Out" – A New ADHD InterventionDo you recognize current ADHD interventions fall short? At DIG Coaching, we've developed a groundbreaking field of engineering called Cognitive Ergonomics from the Inside Out. Discover a fresh approach to ADHD care that looks beyond traditional methods.Learn more at www.cognitive-ergonomics.com

In this episode of Unspoken Security, host AJ Nash sits down with Bob Fabien “BZ” Zinga, a cybersecurity executive and Naval Information Warfare Commander in the U.S. Navy Reserve. They explore how performative leadership shows up in security teams, and why values on a wall fail when pressure hits.BZ argues that optics without accountability kills trust. When leaders bend with politics or budgets, engaged employees go quiet. That silence hides risk. He shares how breaches often trace back to human choices, including a W-2 phishing scam that exposed employees' data and changed his own life. He also pushes blameless postmortems and clear escalation paths.From there, the conversation moves to AI. BZ warns that teams can automate bias and outsource judgment. He calls for guardrails, regulation, and human oversight, especially in high-stakes decisions. He closes with a simple standard: speak up for fairness, even when silence would feel safer.Send a textSupport the show

Maria Brinck is a visionary thought leader devoted to breaking up the traditional leadership monopoly in order to generate the “diversity of thought” necessary to solve our most pressing challenges in organizations and nations. Maria founded Zynergy International, a leadership advisory firm in 2013, to fulfill her passion. Today, Maria works with board members, CEOs, executives, business teams and HR professionals and is based in Colorado. Born and raised in Sweden and Algeria, Maria was educated in Sweden, France, and the USA with a focus on International Business. Her most transformative experience, reshaping her worldview, came when she lived and worked with indigenous people in the Congo Basin Rainforest in a remote part of Cameroon. While working on the rehabilitation of chimpanzees and gorillas, she observed first-hand human planetary destruction and its consequences for all living things, but also the type of leadership we need to bring out the best in humanity. Maria is a Gallup-Certified Strengths Coach and holds a CPCC Certification from CTI, and an ACC Certification from ICF, the International Coach Federation. She previously held positions at GE, Eli Lilly & Co, and Novo Nordisk and some of her current clients include Quanex, Astra-Zeneca, Beacon, DaVita, Vizient and Stryker.